The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? | Blood Cancer Journal
How I manage monoclonal gammopathy of undetermined significance - ScienceDirect
Monoclonal gammopathy of undetermined significance - Wikipedia
Frontiers | Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
The Risk of MGUS Progression to Multiple Myeloma | NEJM Resident 360
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Diagnosis of paraproteinemic neuropathy: Room for improvement - Journal of the Neurological Sciences
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Monoclonal gammopathy and primary care | British Columbia Medical Journal
How to Diagnose Monoclonal Gammopathy of Undetermined Significance – Consult QD
Pseudo-monoclonal gammopathy: a report of four cases | Haematologica
IgM paraprotein and anti-MAG sensory polyneuropathy associated with Waldenstrom's macroglobulinaemia and medullary carcinoma of the thyroid | BMJ Case Reports
IgM paraprotein‐associated peripheral neuropathy: small CD20‐positive B‐cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness - Chen - 2020 - British Journal of Haematology - Wiley Online Library
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
